tiprankstipranks
Advertisement
Advertisement
AbbVie Advances Risankizumab Dosing Study, Signaling Ongoing Immunology Investment
PremiumCompany AnnouncementsAbbVie Advances Risankizumab Dosing Study, Signaling Ongoing Immunology Investment
15d ago
AbbVie Stock (ABBV) Trades at a Discount Despite Fast Growth — a Bullish Case
Premium
Market News
AbbVie Stock (ABBV) Trades at a Discount Despite Fast Growth — a Bullish Case
15d ago
Neutral Hold on AbbVie as Early Cardiometabolic Pipeline Shows Promise but Trails Leading Competitors
Premium
Ratings
Neutral Hold on AbbVie as Early Cardiometabolic Pipeline Shows Promise but Trails Leading Competitors
17d ago
AbbVie’s neuroendocrine carcinoma treatment granted FDA orphan designation
PremiumThe FlyAbbVie’s neuroendocrine carcinoma treatment granted FDA orphan designation
25d ago
AbbVie reports ‘positive’ results from Phase 3 AFFIRM study of Skyrizi
Premium
The Fly
AbbVie reports ‘positive’ results from Phase 3 AFFIRM study of Skyrizi
25d ago
Uber, Verizon, AbbVie, IBM and McDonald’s Insider Shake-Up
Premium
Weekend Updates
Uber, Verizon, AbbVie, IBM and McDonald’s Insider Shake-Up
27d ago
Psychedelic: AtaiBeckley reports EMP-01 met primary objective in Phase 2a trial
PremiumThe FlyPsychedelic: AtaiBeckley reports EMP-01 met primary objective in Phase 2a trial
29d ago
AbbVie initiated with an Outperform at RBC Capital
Premium
The Fly
AbbVie initiated with an Outperform at RBC Capital
1M ago
AbbVie’s Real‑World Vraylar Study in Bipolar I Disorder Reaches Completion
Premium
Company Announcements
AbbVie’s Real‑World Vraylar Study in Bipolar I Disorder Reaches Completion
1M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100